Skip to main navigation Skip to search Skip to main content

An Open-Label, Expanded Access Protocol for Amifampridine Phosphate (3,4-Diaminopyridine Phosphate) Treatment in Patients with Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndrome and Downbeat Nystagmus

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date10/21/15 → 10/20/21

Funding

  • Catalyst Pharmaceuticals Incorporated: $17,840.86